Status:
COMPLETED
Voice Guard Processing Evaluation in a Cohort of Subjects Implanted With the Neuro Cochlear Implant System
Lead Sponsor:
Oticon Medical
Conditions:
Cochlear Implantation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The study aims to compare two different cochlear implant sound processing strategies. All the participants will start off with a sound processing strategy called the XDP (extended performance). At the...
Detailed Description
Voice Guard and XDP are two different cochlear implant sound processing strategies. The Voice Guard sound coding strategy is adaptive in nature and can alter the output from the cochlear implant based...
Eligibility Criteria
Inclusion
- Individuals aged between 18 and 70 years
- Individuals with post-lingual hearing loss
- Individuals with no language and speech production disorders
- Individuals who are native speakers of English
- Individuals meeting NICE candidacy criteria for CI surgery
- Individuals undergoing primary unilateral cochlear implantation
Exclusion
- Medical conditions contraindicating CI surgery
- Individuals with anatomical anomalies of the auditory system
- Individuals with additional mental health issues or and/or cognitive impairment
Key Trial Info
Start Date :
July 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03256097
Start Date
July 25 2018
End Date
May 31 2022
Last Update
January 12 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrooke's Hospital, Cambridge University Hospitals Trust
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ
2
Queen Elizabeth Hospital, University of Birmingham NHS Hospitals Trust
Birmingham, West Midlands, United Kingdom, B15 2TH